Jushi Holdings (JUSHF) Non-Current Debt (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Non-Current Debt came in at $218.5 million in Q1 2026, up 10.95% year-on-year from $196.9 million in Q1 2025, and up 6.14% on a QoQ basis from $205.8 million in Q4 2025.
Jushi Holdings (JUSHF) Non-Current Debt (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Non-Current Debt data on file, last reported at $218.5 million in Q1 2026.
- On a quarterly basis, Non-Current Debt rose 10.95% year-over-year to $218.5 million in Q1 2026; TTM through Mar 2026 was $218.5 million, a 10.95% increase from a year earlier, with the FY2025 full-year figure at $205.8 million, up 10.54% from the prior year.
- Non-Current Debt for Q1 2026 stood at $218.5 million, up from $205.8 million in the prior quarter.
- Over the last five years, Non-Current Debt for JUSHF reached as high as $218.5 million in Q1 2026 and fell as low as $61.9 million in Q3 2022.
- Historically, Non-Current Debt has averaged $180.6 million across 5 years, with a median of $192.7 million in 2024.
- On a YoY basis, Non-Current Debt climbed as much as 242.46% in 2023 and fell as far as 33.4% in 2023.
- Year by year, Non-Current Debt stood at $189.3 million in 2022, then slumped by 33.4% to $126.0 million in 2023, then jumped by 47.74% to $186.2 million in 2024, then increased by 10.54% to $205.8 million in 2025, then gained by 6.14% to $218.5 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $218.5 million in Q1 2026, $205.8 million in Q4 2025, and $204.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 218.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218.47 Mn |
| Dec 31, 2025 | 205.83 Mn |
| Sep 30, 2025 | 204.58 Mn |
| Jun 30, 2025 | 192.83 Mn |
| Mar 31, 2025 | 196.90 Mn |
| Dec 31, 2024 | 186.21 Mn |
| Sep 30, 2024 | 185.49 Mn |
| Jun 30, 2024 | 192.48 Mn |
| Mar 31, 2024 | 207.06 Mn |
| Dec 31, 2023 | 126.04 Mn |
| Sep 30, 2023 | 212.09 Mn |
| Jun 30, 2023 | 213.43 Mn |
| Mar 31, 2023 | 181.61 Mn |
| Dec 31, 2022 | 189.26 Mn |
| Sep 30, 2022 | 61.93 Mn |
| Jun 30, 2022 | 115.68 Mn |
| Dec 31, 2021 | 119.80 Mn |